Author: Schjøtt Jan Pomp Erik Gedde-Dahl Ane
Publisher: Springer Publishing Company
ISSN: 0031-6970
Source: European Journal of Clinical Pharmacology, Vol.57, Iss.12, 2002-02, pp. : 897-902
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
A Problem-Oriented Approach to Safety Issues in Drug Development and Beyond
By Haas J.F.
Drug Safety, Vol. 27, Iss. 8, 2004-01 ,pp. :
By Nilsson G. Hjemdahl P. Hässler A. Vitols S. Wallén N.H. Krakau I.
European Journal of Clinical Pharmacology, Vol. 56, Iss. 11, 2001-01 ,pp. :
The Impact of Thrombopoietin on Clinical Practice
Current Pharmaceutical Design, Vol. 8, Iss. 5, 2002-03 ,pp. :
Do physicians consider cost effectiveness in clinical practice?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 301, 2001-01 ,pp. :